PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING OBESITY

摘要

A clustered mitochondrial homolog (CLUH) or a BMP binding endothelia regulator (BMPER) according to the present invention is involved in differentiation into adipocytes and fat accumulation. Thus, by inhibiting the CLUH or the BMPER, differentiation into adipocytes can be inhibited and obesity can be treated or prevented. Also, by measuring the level of expression of the CLUH or the BMPER, obesity can be diagnosed and screening of an obesity treating agent or a control agent for differentiation into adipocytes is enabled.